Crucell N.V. Q3 Profit Falls 22%, Keeps Outlook

Reuters -- Dutch biotech firm Crucell reiterated its full-year revenue outlook despite reporting lower-than-expected net profit for the second consecutive quarter, as its revenues disappointed.